Prothena Corp. Plc PRTA 深 滬
等待開盤 05-13 09:30:00 美东时间
9.43
-0.240
-2.48%
華盛通- 最 高9.82
- 今 開9.67
- 成交量 49.51万股
- 最 低 9.285
- 昨 收 9.67
- 總市值 5.08亿
- 52周最高 11.80
- 市盈率 靜 --
- 換手率 0.92%
- 52周最低 4.32
- 委 比 -88.96%
- 總股本 5383.30万
- 歷史最高 79.749
- 量 比 0.88
- 振 幅 5.53%
- 歷史最低 4.32
- 每 手 1
- 風險率 1.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Citizens Maintains Market Outperform on Prothena Corp, Raises Price Target to $20
Citizens analyst Jason N. Butler maintains Prothena Corp (NASDAQ:PRTA) with a Market Outperform and raises the price target from $19 to $20.
05-08 23:15
Prothena Announces Coramitug Amyloid Depleter Antibody Receives FDA's Fast Track Designation To Treat ATTR Amyloidosis With Cardiomyopathy
Prothena Corporation plc (NASDAQ:PRTA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to coramitug, a potential best-in-class amyloid depleter antibody currently in
04-28 04:12
新浪财经ESG：Prothena Corporation plc MSCI（明晟）ESG评级调降至BBB
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:28
Prothena Announces $100 Million Share Repurchase Program
Prothena ( ($PRTA) ) has shared an announcement. On February 27, 2026, Prothena...
02-28 06:42
Prothena shares are trading higher after the company announced a $100 million share buyback.
Prothena shares are trading higher after the company announced a $100 million s...
02-28 05:17
美股大行评级 | 潜在涨幅214.14%！HC Wainwright & Co.：Ardelyx获机构升目标价至18美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Ardelyx"买入"评级，目标价从10美元升至18美元；Truist Securities：维持Praxis Precision Medicine"买入"评级，目标价从500美元升至700美元
02-23 08:56
Prothena Earnings Call: Pipeline Progress, Risks Ahead
Prothena Corporation (($PRTA)) has held its Q4 earnings call. Read on for the m...
02-22 08:15
RBC Capital Maintains Sector Perform on Prothena Corp, Raises Price Target to $12
RBC Capital analyst Brian Abrahams maintains Prothena Corp (NASDAQ:PRTA) with a Sector Perform and raises the price target from $11 to $12.
02-21 00:31
Prothena Corp Q4 Earnings Assessment
Prothena Corp (NASDAQ:PRTA) released its Q4 earnings on Thursday, February 19, ...
02-20 05:14
